Creative Planning Adaptive Biotechnologies Corp Transaction History

Creative Planning

$103 Billion
Q4 2024

A detailed history of Creative Planning transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Creative Planning holds 51,558 shares of ADPT stock, worth $434,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,558

Previous 49,324 4.53%

Holding current value

$434,118

Previous $252,000 22.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.37 - $6.78 $9,762 - $15,146	2,234 Added 4.53%	51,558 $309,000
Q3 2024 Oct 11, 2024	BUY	$3.37 - $5.12 $6,463 - $9,820	1,918 Added 4.05%	49,324 $252,000
Q2 2024 Aug 15, 2024	BUY	$2.34 - $3.96 $58,387 - $98,809	24,952 Added 111.12%	47,406 $171,000
Q1 2024 May 10, 2024	BUY	$2.88 - $4.8 $6,168 - $10,281	2,142 Added 10.55%	22,454 $72,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $657 - $1,012	190 Added 0.94%	20,312 $99,000
Q3 2023 Nov 16, 2023	SELL	$5.07 - $8.44 $42,623 - $70,955	-8,407 Reduced 29.47%	20,122 $109,000
Q2 2023 Jul 21, 2023	BUY	$6.19 - $8.78 $45,168 - $64,067	7,297 Added 34.37%	28,529 $191,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $826 - $1,071	106 Added 0.5%	21,232 $187,000
Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $11,812 - $17,624	1,887 Added 9.81%	21,126 $161,000
Q3 2022 Nov 03, 2022	BUY	$6.5 - $12.67 $611 - $1,190	94 Added 0.49%	19,239 $137,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $832 - $1,914	-130 Reduced 0.67%	19,145 $155,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $1,325 - $3,785	131 Added 0.68%	19,275 $268,000
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $5,940 - $8,696	-236 Reduced 1.22%	19,144 $537,000
Q2 2021 Aug 04, 2021	SELL	$32.22 - $44.59 $42,111 - $58,279	-1,307 Reduced 6.32%	19,380 $792,000
Q1 2021 Apr 30, 2021	SELL	$37.26 - $67.74 $94,006 - $170,908	-2,523 Reduced 10.87%	20,687 $833,000
Q4 2020 Jan 29, 2021	SELL	$45.01 - $65.47 $400,453 - $582,486	-8,897 Reduced 27.71%	23,210 $1.37 Million
Q3 2020 Nov 05, 2020	BUY	$35.79 - $48.81 $23,514 - $32,068	657 Added 2.09%	32,107 $1.56 Million
Q2 2020 Jul 23, 2020	BUY	$24.95 - $48.38 $4,990 - $9,676	200 Added 0.64%	31,450 $1.52 Million
Q1 2020 May 05, 2020	BUY	$16.96 - $34.16 $530,000 - $1.07 Million	31,250 New	31,250 $868,000

Others Institutions Holding ADPT

# of Institutions

225

Shares Held

146M

Call Options Held

19.6K

Put Options Held

27.2K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.2B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Adaptive Biotechnologies Corp Transaction History